Unveiling 4 Analyst Insights On Genelux
Portfolio Pulse from Benzinga Insights
Genelux (NASDAQ:GNLX) has been analyzed by four analysts, revealing a mix of bullish and somewhat bullish sentiments. The average 12-month price target is $29.75, down 8.46% from the previous $32.50. Key analysts have adjusted their ratings and price targets, reflecting dynamic market conditions and company performance. Genelux faces financial challenges, including a significant revenue decline and below-average profitability metrics.
May 31, 2024 | 4:01 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Genelux has received mixed analyst ratings, with an average price target of $29.75, down from $32.50. The company faces significant financial challenges, including a 95.29% revenue decline and below-average profitability metrics.
The mixed analyst ratings and lowered price targets indicate a cautious outlook on Genelux. The significant revenue decline and poor profitability metrics further suggest potential short-term downward pressure on the stock price.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100